Piper Sandler Maintains Overweight on Stryker, Lowers Price Target to $390

Benzinga Newsdesk www.benzinga.com Negative 86.0%

Neg 86% Neu 0% Pos 0%

Piper Sandler analyst Matt O'Brien maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $420 to $390.